Performing FDA 510K enabling studies for a diagnostic to detect ciprofloxicin resistance or susceptability
Active Awarded Last action
- Contract number
- 75N93026F00003
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,571,051
Award facts
- Opportunity
-
- E22 Solicitation number
- Contract value 100% obligated
- $1,571,051.00 Current and potential, with all options
- Completion date 55% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Kansas City, MO 64110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,571,051 | |
| Original award | $0 |
About this award
The National Institute of Allergy and Infectious Diseases issued a $1,571,051 delivery order to Mriglobal on May 4, 2026, for FDA 510(k) enabling studies to detect ciprofloxacin resistance or susceptibility in a diagnostic product, with a completion date of March 10, 2027.
Place of performance is Kansas City, Missouri. The order is issued under firm fixed price terms with no set-aside applied. Mriglobal, doing business as Midwest Research Institute, is a Kansas City-based 501(c)(3) nonprofit research organization providing clinical-grade pharmaceutical manufacturing, preclinical testing, and diagnostic services to federal agencies as a large, unrestricted prime contractor. The organization operates laboratory facilities across multiple locations, including a headquarters facility with 60,000 square feet of laboratory space.
Quick answers
Who was awarded contract 75N93026F00003?
75N93026F00003 was awarded to Mriglobal by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 4, 2026.
How much is contract 75N93026F00003 worth?
The government has obligated $1,571,051 on 75N93026F00003.
Is contract 75N93026F00003 an order under another contract?
Yes. 75N93026F00003 is a delivery order under 75N93023D00017, an indefinite delivery contract.
Was contract 75N93026F00003 competed?
The extent of competition for 75N93026F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award